DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Telemark Asset Management, LLC established a new position in Moderna ( MRNA 1.26%), acquiring 500,000 shares valued at approximately $12.91 million as of September 30, 2025, according to a November 10 ...

Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...

The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

The biotechnology market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments, and advancements in cell technologies. Surge in ...

As major U.S. stock indexes continue to set fresh records, investors are closely watching the Federal Reserve's latest moves and the potential impact on market trends. In this context, penny ...

Sana's first-in-human study shows HIP technology allows islet cells to avoid immune rejection and produce insulin without immunosuppression. Reliance on initial results: The press release heavily ...

America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...